Table 1.
Potential inhibitors for SARS-CoV-2.
| Drug | CAS | Target | Predicted Affinity (nM) |
|---|---|---|---|
| Abacavir (sulfate) | 188062-50-2 | RdRp helicase |
3.03 3.06 |
| Darunavir | 206361-99-1 | 3CLpro PLpro |
57.30 46.16 |
| Darunavir (ethanolate) | 635728-49-3 | 3CLpro PLpro |
44.51 35.86 |
| Itraconazole | 84625-61-6 | PLpro RdRp |
127.98 16.90 |
| Almitrine mesylate | 29608-49-9 | 3CLpro | 29.31 |
| Daclatasvir | 1009119-64-5 | RdRp | 15.03 |
| Daclatasvir (dihydrochloride) | 1009119-65-6 | RdRp | 19.87 |
| Metoprolol tartrate | 56392-17-7 | PLpro | 153.23 |
| Fiboflapon sodium | 1196070-26-4 | PLpro | 197.63 |
| Roflumilast | 162401-32-3 | 3CLpro | 248.89 |